Circulating levels of miR-146a and IL-17 are significantly correlated with the clinical activity of graves′ ophthalmopathy

Endocrine Journal

Volumn 61, Issue 11, 2014, Pages 1087-1092

  Wei, Hongfa ^a   Guan, Meiping ^a   Qin, Yan ^a   Xie, Cuihua ^a   Fu, Xiajun ^a   Gao, Fang ^a   Xue, Yaoming ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Clinical activity score; Graves ophthalmopathy; Interleukin 17; microRNA

Indexed keywords

BIOLOGICAL MARKER; INTERLEUKIN 17; MICRORNA 146A; MICRORNA; MIRN146 MICRORNA, HUMAN;

ADULT; ARTICLE; CLINICAL ACTIVITY SCORE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ENDOCRINE OPHTHALMOPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SCORING SYSTEM; BLOOD; GRAVES DISEASE; MIDDLE AGED; PATHOPHYSIOLOGY;

ADULT; FEMALE; GRAVES DISEASE; GRAVES OPHTHALMOPATHY; HUMANS; INTERLEUKIN-17; MALE; MICRORNAS; MIDDLE AGED;

EID: 84912079229     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ14-0246     Document Type: Article

References (26)

1. Bahn RS (2003) Clinical review 157: Pathophysiology of Graves’ ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab 88: 1939-1946.
2. Pedersen I, David M (2008) MicroRNAs in the immune response. Cytokine 43: 391-394.
3. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
4. Abou-Zeid A, Saad M, Soliman E (2011) MicroRNA 146a expression in rheumatoid arthritis: association with tumor necrosis factor-alpha and disease activity. Genet Test Mol Biomarkers 15: 807-812.
5. Wang H, Peng W, Ouyang X, Li W, Dai Y (2012) Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl Res 160: 198-206.
6. Waschbisch A, Atiya M, Linker RA, Potapov S, Schwab S, et al. (2011) Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis. PLoS One 6: e24604.
7. Nahid MA, Pauley KM, Satoh M, Chan EK (2009) miR-146a is critical for endotoxin-induced tolerance: IMPLICATION IN INNATE IMMUNITY. J Biol Chem 284: 34590-34599.
8. Dai R, Phillips RA, Zhang Y, Khan D, Crasta O, et al. (2008) Suppression of LPS-induced Interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: a novel mechanism of immune modulation. Blood 112: 4591-4597.
9. Taganov KD, Boldin MP, Chang KJ, Baltimore D (2006) NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103: 12481-12486.
10. Niimoto T, Nakasa T, Ishikawa M, Okuhara A, Izumi B, et al. (2010) MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients. BMC Musculoskelet Disord 11: 209.
11. Kim SE, Yoon JS, Kim KH, Lee SY (2012) Increased serum interleukin-17 in Graves’ ophthalmopathy. Graefes Arch Clin Exp Ophthalmol 250: 1521-1526.
12. Han R, Smith TJ (2006) T helper type 1 and type 2 cytokines exert divergent influence on the induction of prostaglandin E2 and hyaluronan synthesis by interleukin-1beta in orbital fibroblasts: implications for the pathogenesis of thyroid-associated ophthalmopathy. Endocrinology 147: 13-19.
13. Miossec P (2009) IL-17 and Th17 cells in human inflammatory diseases. Microbes Infect 11: 625-630.
14. Bettelli E, Korn, T, Oukka M, Kuchroo VK (2008) Induction and effector functions of T(H)17 cells. Nature 453: 1051-1057.
15. Iwakura Y, Nakae S, Saijo S, Ishigame H (2008) The roles of IL-17A in inflammatory immune responses and host defense against pathogens. Immunol Rev 226: 57-79.
16. Wong CK, Lit LC, Tam LS, Li EK, Wong PT, et al. (2008) Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol 127: 385-393.
17. Hueber AJ, Asquith DL, Miller AM, Reilly J, Kerr S, et al. (2010) Mast cells express IL-17A in rheumatoid arthritis synovium. J Immunol 184: 3336-3340.
18. Matusevicius D, Kivisakk P, He B, Kostulas N, Ozenci V, et al. (1999) Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis. Mult Scler 5: 101-104.
19. Bullens DM, Truyen E, Coteur L, Dilissen E, Hellings PW, et al. (2006) IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res 7: 135.
20. Boldin MP, Taganov KD, Rao DS, Yang L, Zhao JL, et al. (2011) miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J Exp Med 208: 1189-1201.
21. Maitra U, Davis S, Reilly CM, Li L (2009) Differential regulation of Foxp3 and IL-17 expression in CD4 T helper cells by IRAK-1. J Immunol 182: 5763-5769.
22. Pauley KM, Satoh M, Chan AL, Bubb MR, Reeves WH, et al. (2008) Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther 10: R101.
23. Nakasa T, Miyaki S, Okubo A, Hashimoto M, Nishida K, et al. (2008) Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 58: 1284-1292.
24. Wang G, Tam LS, Li EK, Kwan BC, Chow KM, et al. (2010) Serum and urinary cell-free MiR-146a and MiR-155 in patients with systemic lupus erythematosus. J Rheumatol 37: 2516-2522.
25. Bernecker C, Lenz L, Ostapczuk MS, Schinner S, Willenberg H, et al. (2012) MicroRNAs miR-146a1, miR-155_2, and miR-200a1 are regulated in autoimmune thyroid diseases. Thyroid 22: 1294-1295.
26. Xia P, Fang X, Zhang ZH, Huang Q, Yan KX, et al. (2012) Dysregulation of miRNA146a versus IRAK1 induces IL-17 persistence in the psoriatic skin lesions. Immunol Lett 148: 151-162.